Original InvestigationRenal Denervation in High-Risk Patients With Hypertension
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
The Global SYMPLICITY Registry is funded by Medtronic. Prof. Mahfoud is supported by Deutsche Gesellschaft für Kardiologie and Deutsche Forschungsgemeinschaft; and has received speaker honoraria from Medtronic and ReCor. Prof. Mancia has received speaker fees from Boehringer Ingelheim, Ferrer, Gedeon Richter, Medtronic Vascular, Menarini, Merck Healthcare KGaA, Neopharmed-Gentili, Novartis, Recordati, Sanofi, and Servier. Prof. Schmieder has received speaker and consulting honoraria from Medtronic, ReCor, Ablative Solutions, and Rox Medical. Prof. Narkiewicz has received speaker honoraria from Adamed, Berlin-Chemie/Menarini, Egis, Gedeon Richter, Krka, Polpharma, Sandoz, and Servier; and has received honoraria or consultation fees from Medtronic, Servier, Krka, Berlin-Chemie/Menarini, Egis, Sandoz, Idorsia, Polpharma, and Gedeon Richter. Prof. Ruilope has served as an advisor/speaker for Medtronic. Prof. Schlaich is supported by an NHMRC Senior Research Fellowship; and has received consulting fees and/or travel and research support from Medtronic, Abbott, Novartis, Servier, Pfizer, and Boehringer Ingelheim. Prof. Zeller has received honoraria from Abbott Vascular, B. Braun, Biotronik, Boston Scientific, Cook Medical, Gore & Associates, Medtronic, Philips-Spectranetics, TriReme, Veryan, and Shockwave; has received consulting fees from Boston Scientific, Cook Medical, Gore & Associates, Medtronic, Spectranetics, Veryan, Intact Vascular, MedAlliance, and Vesper Medical; and owns stock in QT Medical. Prof. Stawowy has received consultancy and lecture honoraria from Amgen, Novartis, San, Bristol-Myers Squibb/Pfizer, Daiichi-Sankyo, Bayer, Boehringer Ingelheim, BerlinChemie, B. Braun, Springer Nature, Medtronic, and AstraZeneca. Dr. Cohen is an employee of and owns stock in Medtronic. Mr. Fahy is an employee of Medtronic. Prof. Böhm is supported by the Deutsche Forschungsgemeinschaft (DFG, TRR-219, S-01, M-03, M-05); and has received personal fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Servier, Medtronic, Vifor, Novartis, and Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.